Part Details | THEOPHYLLINE EXTENDED-RELEASE TABLETS
6505-01-159-9250
Alternate Parts: NDC00087051941, NDC00087-0519-41, QUIBRONTSR, QUIBRON-T/SR, NDC61570001901, NDC61570-0019-01, 6505-01-159-9250, 01-159-9250, 6505011599250, 011599250
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | AUG 14, 1983 | 01-159-9250 | 42612 ( THEOPHYLLINE EXTENDED-RELEASE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-159-9250
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00087-0519-41 | 13811 | BRISTOL-MYERS SQUIBB COWESTWOOD-SQUIBB PHARMACEUTICALS DIV |
| QUIBRON-T/SR | 29398 | MEAD JOHNSON & COMPANY, LLCDBA MEAD JOHNSON NUTRITION |
| NDC61570-0019-01 | 09GL2 | MONARCH PHARMACEUTICALS INC |
Technical Data | NSN 6505-01-159-9250
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB300.000 MILLIGRAMS THEOPHYLLINE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| THERAPEUTIC EQUIVALENT | QUIBRON-T/SR BY BRISTOL-MYERS SQUIBB PHARMACEUTICAL |
| SPECIAL FEATURES | ANHYDROUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT |